CWICX
Price
$80.04
Change
+$0.50 (+0.63%)
Updated
Jun 25 closing price
Net Assets
159.53B
MSEFX
Price
$11.64
Change
+$0.04 (+0.34%)
Updated
Jun 25 closing price
Net Assets
76.79M
Interact to see
Advertisement

CWICX vs MSEFX

CWICX vs MSEFX Comparison Chart in %
View a ticker or compare two or three
VS
CWICX vs. MSEFX commentary
Jun 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWICX is a Buy and MSEFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWICX has more cash in the bank: 160B vs. MSEFX (76.8M). CWICX pays higher dividends than MSEFX: CWICX (0.69) vs MSEFX (0.27). CWICX was incepted earlier than MSEFX: CWICX (24 years) vs MSEFX (30 years). CWICX (1.52) is less costly to investors than MSEFX (1.25). MSEFX is a more actively managed with annual turnover of: 81.15 vs. CWICX (44.00). CWICX has a lower initial minimum investment than MSEFX: CWICX (250) vs MSEFX (10000). CWICX annual gain was more profitable for investors over the last year : 15.74 vs. MSEFX (-1.50). CWICX return over 5 years is better than : 28.47 vs. MSEFX (-46.06).
CWICXMSEFXCWICX / MSEFX
Total Expense Ratio1.520.94162%
Annual Report Gross Expense Ratio1.521.25122%
Fund Existence24 years30 years-
Gain YTD12.373-1.612-768%
Front LoadN/AN/A-
Min. Initial Investment250100003%
Min. Initial Investment IRAN/AN/A-
Net Assets160B76.8M208,333%
Annual Yield % from dividends0.690.27253%
Returns for 1 year15.74-1.50-1,050%
Returns for 3 years46.320.984,749%
Returns for 5 years28.47-46.06-62%
Returns for 10 years114.36-22.98-498%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BHCFX21.230.39
+1.87%
Baron Health Care Retail
EPLIX25.260.07
+0.28%
NYLI Epoch U.S. Equity Yield Inv Class
JPVZX21.05N/A
N/A
JPMorgan Developed International ValueR2
BQLCX21.78N/A
N/A
Bright Rock Quality Large Cap Instl
OIERX27.64N/A
N/A
JPMorgan Equity Income R5